• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sao Paulo Med J . Clinical characteristics and outcomes among Brazilian patients with severe acute respiratory syndrome coronavirus 2 infection: an

tetano

Editor, Senior Moderator
Sao Paulo Med J


. 2020 Nov 27;S1516-31802020005028202.
doi: 10.1590/1516-3180.2020.00365.R1.08092020. Online ahead of print.
Clinical characteristics and outcomes among Brazilian patients with severe acute respiratory syndrome coronavirus 2 infection: an observational retrospective study


Israel J?nior Borges do Nascimento[SUP] 1 [/SUP], Luiz Ricardo Pinto[SUP] 2 [/SUP], Val?ria Alves Fernandes[SUP] 3 [/SUP], Israel Molina Romero[SUP] 4 [/SUP], Jo?o Antonio de Queiroz Oliveira[SUP] 5 [/SUP], Milena Soriano Marcolino[SUP] 6 [/SUP], Maria F?tima Leite[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Since February 2020, data on the clinical features of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their clinical evolution have been gathered and intensively discussed, especially in countries with dramatic dissemination of this disease.
Objective: To assess the clinical features of Brazilian patients with SARS-CoV-2 and analyze its local epidemiological features.
Design and setting: Observational retrospective study conducted using data from an official electronic platform for recording confirmed SARS-CoV-2 cases.
Methods: We extracted data from patients based in the state of Pernambuco who were registered on the platform of the Center for Strategic Health Surveillance Information, between February 26 and May 25, 2020. Clinical signs/symptoms, case evolution over time, distribution of confirmed, recovered and fatal cases and relationship between age group and gender were assessed.
Results: We included 28,854 patients who were positive for SARS-CoV-2 (56.13% females), of median age 44.18 years. SARS-CoV-2 infection was most frequent among adults aged 30-39 years. Among cases that progressed to death, the most frequent age range was 70-79 years. Overall, the mortality rate in the cohort was 8.06%; recovery rate, 30.7%; and hospital admission rate (up to the end of follow-up), 17.3%. The average length of time between symptom onset and death was 10.3 days. The most commonly reported symptoms were coughing (42.39%), fever (38.03%) and dyspnea/respiratory distress with oxygen saturation < 95% (30.98%).
Conclusion: Coughing, fever and dyspnea/respiratory distress with oxygen saturation < 95% were the commonest symptoms. The case-fatality rate was 8.06% and the hospitalization rate, 17.3%.
 
Back
Top Bottom